Abstract
Despite being in the same pathway, mutations of KRAS and BRAF in colorectal carcinomas (CRCs) determine distinct progression courses. ZEB1 induces an ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
